Kodiak Sciences (KOD) Net Equity Issued and Repurchased (2018 - 2019)

Kodiak Sciences (KOD) posted Net Equity Issued and Repurchased of $297.6 million for Q4 2019, up 99100.0% on a QoQ basis from $300000.0 in Q3 2019, and up 255.53% year-over-year from $83.7 million in Q4 2018.

Kodiak Sciences (KOD) Net Equity Issued and Repurchased (2018 - 2019) Analysis & Trends

Kodiak Sciences' Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $297.6 million for Q4 2019.

  • Quarterly Net Equity Issued and Repurchased rose 255.53% year-over-year to $297.6 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $298.0 million (up 255.82% YoY) and the FY2020 annual result came in at $612.0 million, up 105.64% from the prior year.
  • Net Equity Issued and Repurchased was $297.6 million for Q4 2019 at Kodiak Sciences, up from $300000.0 in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $297.6 million in Q4 2019 and bottomed at $31000.0 in Q2 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Kodiak Sciences 2.54 Bn 2.54 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2019 297.60 Mn
Dec 31, 2019 297.60 Mn
Sep 30, 2019 300,000.00
Sep 30, 2019 300,000.00
Jun 30, 2019 31,000.00
Jun 30, 2019 31,000.00
Mar 31, 2019 83,000.00
Mar 31, 2019 83,000.00
Dec 31, 2018 83.71 Mn
Dec 31, 2018 83.71 Mn
Sep 30, 2018 49,000.00
Sep 30, 2018 49,000.00